Pulmonary functional magnetic resonance imaging for paediatric lung disease

Paediatric Respiratory Reviews

Volumn 14, Issue 3, 2013, Pages 180-189

  Kirby, Miranda ^a,b   Coxson, Harvey O ^c   Parraga, Grace ^a,b,d  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Graduate Program in Biomedical Engineering   (Canada)

Author keywords

Apparent diffusion coefficient; Asthma; Cystic fibrosis; Hyperpolarised helium 3 MRI; MRI; Ventilation defect

Indexed keywords

BRONCHODILATING AGENT; HELIUM; METHACHOLINE; SALBUTAMOL; XENON;

ASTHMA; BREATHING EXERCISE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FORCED EXPIRATORY VOLUME; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INTERMETHOD COMPARISON; IONIZING RADIATION; LONGITUDINAL STUDY; LUNG DEVELOPMENT; LUNG DISEASE; LUNG FUNCTION; LUNG VENTILATION; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; PATIENT MONITORING; PATIENT SAFETY; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SIGNAL NOISE RATIO; SPIROMETRY; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

APPARENT DIFFUSION COEFFICIENT; ASTHMA; CYSTIC FIBROSIS; HYPERPOLARISED HELIUM-3 MRI; MRI; VENTILATION DEFECT;

ASTHMA; CHILD; CHRONIC DISEASE; CYSTIC FIBROSIS; DISEASE PROGRESSION; HUMANS; LUNG DISEASES; MAGNETIC RESONANCE IMAGING; RESPIRATORY FUNCTION TESTS;

EID: 84881555220     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2013.02.007     Document Type: Review

References (103)

1. Arthur R. Interpretation of the paediatric chest X-ray. Paediatr Respir Rev 2000, 1:41-50.
2. Lynch D.A., Brasch R.C., Hardy K.A., Webb W.R. Pediatric pulmonary disease: assessment with high-resolution ultrafast CT. Radiology 1990, 176:243-248.
3. Schauer D.A., Linton O.W. National Council on Radiation Protection and Measurements report shows substantial medical exposure increase. Radiology 2009, 253:293-296.
4. Mettler F.A., Wiest P.W., Locken J.A., Kelsey C.A. CT scanning: patterns of use and dose. J Radiol Prot 2000, 20:353-359.
5. Brenner D., Elliston C., Hall E., Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 2001, 176:289-296.
6. Pearce M.S., Salotti J.A., Little M.P., et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012, 380:499-505.
7. Smith J.J., Sorensen A.G., Thrall J.H. Biomarkers in imaging: realizing radiology's future. Radiology 2003, 227:633-638.
8. Bergin C.J., Glover G.M., Pauly J. Magnetic resonance imaging of lung parenchyma. J Thorac Imaging 1993, 8:12-17.
9. Owrangi A.M., Parraga G. Chest MRI in children: Why bother?. Respirology 2012, 17:3-4.
10. Muller N.L., Mayo J.R., Zwirewich C.V. Value of MR imaging in the evaluation of chronic infiltrative lung diseases: comparison with CT. AJR Am J Roentgenol 1992, 158:1205-1209.
11. Mayo J.R., MacKay A., Muller N.L. MR imaging of the lungs: value of short TE spin-echo pulse sequences. AJR Am J Roentgenol 1992, 159:951-956.
12. Deimling M, Jellus V, Geiger B, Chefd'hotel C., Time Resolved Lung Ventilation Imaging by Fourier Decomposition. Proceedings of the 16th Annual Meeting of ISMRM, Toronto, Canada, 2639. 2008. Ref Type: Abstract.
13. Bauman G., Scholz A., Rivoire J., et al. Lung ventilation- and perfusion-weighted Fourier decomposition magnetic resonance imaging: In vivo validation with hyperpolarized (3) He and dynamic contrast-enhanced MRI. Magn Reson Med 2012.
14. Bauman G., Lutzen U., Ullrich M., et al. Pulmonary functional imaging: qualitative comparison of Fourier decomposition MR imaging with SPECT/CT in porcine lung. Radiology 2011, 260:551-559.
15. Bauman G., Puderbach M., Deimling M., et al. Non-contrast-enhanced perfusion and ventilation assessment of the human lung by means of fourier decomposition in proton MRI. Magn Reson Med 2009, 62:656-664.
16. Eichinger M., Optazaite D.E., Kopp-Schneider A., et al. Morphologic and functional scoring of cystic fibrosis lung disease using MRI. Eur J Radiol 2012, 81:1321-1329.
17. Puderbach M., Eichinger M., Gahr J., et al. Proton MRI appearance of cystic fibrosis: comparison to CT. Eur Radiol 2007, 17:716-724.
18. Eichinger M., Puderbach M., Fink C., et al. Contrast-enhanced 3D MRI of lung perfusion in children with cystic fibrosis--initial results. Eur Radiol 2006, 16:2147-2152.
19. Bauman G, Heimann T, Fitzsching E, Semmler W, Puderbach M, Eichinger M. Automated assessment of regional lung perfusion in cystic fibrosis patients by using Fourier decomposition MRI. Proceedings of the 20th Annual Meeting of ISMRM, Melbourne, Australia, 625. 2012. Ref Type: Abstract.
20. Edelman R.R., Hatabu H., Tadamura E., Li W., Prasad P.V. Noninvasive assessment of regional ventilation in the human lung using oxygen-enhanced magnetic resonance imaging. Nat Med 1996, 2:1236-1239.
21. Chen Q., Jakob P.M., Griswold M.A., Levin D.L., Hatabu H., Edelman R.R. Oxygen enhanced MR ventilation imaging of the lung. MAGMA 1998, 7:153-161.
22. Stock K.W., Chen Q., Morrin M., Hatabu H., Edelman R.R. Oxygen-enhanced magnetic resonance ventilation imaging of the human lung at 0.2 and 1.5 T. J Magn Reson Imaging 1999, 9:838-841.
23. Loffler R., Muller C.J., Peller M., et al. Optimization and evaluation of the signal intensity change in multisection oxygen-enhanced MR lung imaging. Magn Reson Med 2000, 43:860-866.
24. Ohno Y., Hatabu H., Takenaka D., Adachi S., Van C.M., Sugimura K. Oxygen-enhanced MR ventilation imaging of the lung: preliminary clinical experience in 25 subjects. AJR Am J Roentgenol 2001, 177:185-194.
25. Kauczor H.U., Ebert M., Kreitner K.F., et al. Imaging of the lungs using 3He MRI: preliminary clinical experience in 18 patients with and without lung disease. J Magn Reson Imaging 1997, 7:538-543.
26. de Lange E.E., Mugler J.P., Brookeman J.R., et al. Lung air spaces: MR imaging evaluation with hyperpolarized 3He gas. Radiology 1999, 210:851-857.
27. Moller H.E., Chen X.J., Saam B., et al. MRI of the lungs using hyperpolarized noble gases. Magn Reson Med 2002, 47:1029-1051.
28. Albert M.S., Cates G.D., Driehuys B., et al. Biological magnetic resonance imaging using laser-polarized 129Xe. Nature 1994, 370:199-201.
29. Mugler J.P., Driehuys B., Brookeman J.R., et al. MR imaging and spectroscopy using hyperpolarized 129Xe gas: preliminary human results. Magn Reson Med 1997, 37:809-815.
30. Mugler JP, III, Mata JF, Wang HTJ, Tobias WA, Cates GD, Christopher JM, et al. The apparent diffusion coefficient of 129-Xe in the lung: preliminary human results. Proceedings of the 12th Annual Meeting of ISMRM, Kyoto, Japan, 769. 2004. Ref Type: Abstract.
31. Sindile A, Muradian I, Hrovat M, Johnson DC, Hersman FW, Patz S. Human pulmonary diffusion weighted imaging at 0.2T with hyperpolarizd 129Xe. Proceedings of the 15th Annual Meeting of ISMRM, Berlin, Germany, 1290. 2007. Ref Type: Abstract.
32. Patz S., Hersman F.W., Muradian I., et al. Hyperpolarized (129)Xe MRI: a viable functional lung imaging modality?. Eur J Radiol 2007, 64:335-344.
33. Patz S., Muradian I., Hrovat M.I., et al. Human pulmonary imaging and spectroscopy with hyperpolarized 129Xe at 0.2T. Acad Radiol 2008, 15:713-727.
34. Cleveland Z.I., Cofer G.P., Metz G., et al. Hyperpolarized Xe MR imaging of alveolar gas uptake in humans. PLoS One 2010, 5:e12192.
35. Mugler J.P., Altes T.A., Ruset I.C., et al. Simultaneous magnetic resonance imaging of ventilation distribution and gas uptake in the human lung using hyperpolarized xenon-129. Proc Natl Acad Sci U S A 2010, 107:21707-21712.
36. Kaushik S.S., Cleveland Z.I., Cofer G.P., et al. Diffusion-weighted hyperpolarized 129Xe MRI in healthy volunteers and subjects with chronic obstructive pulmonary disease. Magn Reson Med 2011, 65:1154-1165.
37. Dregely I., Mugler J.P., Ruset I.C., et al. Hyperpolarized Xenon-129 gas-exchange imaging of lung microstructure: first case studies in subjects with obstructive lung disease. J Magn Reson Imaging 2011, 33:1052-1062.
38. Driehuys B., Martinez-Jimenez S., Cleveland Z.I., et al. Chronic obstructive pulmonary disease: safety and tolerability of hyperpolarized 129Xe MR imaging in healthy volunteers and patients. Radiology 2012, 262:279-289.
39. Dregely I., Ruset I.C., Mata J.F., et al. Multiple-exchange-time xenon polarization transfer contrast (MXTC) MRI: initial results in animals and healthy volunteers. Magn Reson Med 2012, 67:943-953.
40. Driehuys B., Cofer G.P., Pollaro J., Mackel J.B., Hedlund L.W., Johnson G.A. Imaging alveolar-capillary gas transfer using hyperpolarized 129Xe MRI. Proc Natl Acad Sci U S A 2006, 103:18278-18283.
41. Muller C.J., Schwaiblmair M., Scheidler J., et al. Pulmonary diffusing capacity: assessment with oxygen-enhanced lung MR imaging preliminary findings. Radiology 2002, 222:499-506.
42. Ohno Y., Hatabu H., Takenaka D., Van C.M., Fujii M., Sugimura K. Dynamic oxygen-enhanced MRI reflects diffusing capacity of the lung. Magn Reson Med 2002, 47:1139-1144.
43. Ohno Y., Koyama H., Yoshikawa T., et al. Comparison of capability of dynamic O(2)-enhanced MRI and quantitative thin-section MDCT to assess COPD in smokers. Eur J Radiol 2012, 81:1068-1075.
44. Ohno Y., Koyama H., Matsumoto K., et al. Oxygen-enhanced MRI vs. quantitatively assessed thin-section CT: pulmonary functional loss assessment and clinical stage classification of asthmatics. Eur J Radiol 2011, 77:85-91.
45. Ohno Y., Iwasawa T., Seo J.B., et al. Oxygen-enhanced magnetic resonance imaging versus computed tomography: multicenter study for clinical stage classification of smoking-related chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 177:1095-1102.
46. Ohno Y., Koyama H., Nogami M., et al. Dynamic oxygen-enhanced MRI versus quantitative CT: pulmonary functional loss assessment and clinical stage classification of smoking-related COPD. AJR Am J Roentgenol 2008, 190:W93-W99.
47. Jakob P.M., Wang T., Schultz G., Hebestreit H., Hebestreit A., Hahn D. Assessment of human pulmonary function using oxygen-enhanced T(1) imaging in patients with cystic fibrosis. Magn Reson Med 2004, 51:1009-1016.
48. Yablonskiy D.A., Sukstanskii A.L., Leawoods J.C., et al. Quantitative in vivo assessment of lung microstructure at the alveolar level with hyperpolarized 3He diffusion MRI. Proc Natl Acad Sci U S A 2002, 99:3111-3116.
49. Lutey B.A., Lefrak S.S., Woods J.C., et al. Hyperpolarized 3He MR imaging: physiologic monitoring observations and safety considerations in 100 consecutive subjects. Radiology 2008, 248:655-661.
50. Ruset I.C., Ketel S., Hersman F.W. Optical pumping system design for large production of hyperpolarized. Phys Rev Lett 2006, 96:053002.
51. Hersman F.W., Ruset I.C., Ketel S., et al. Large production system for hyperpolarized 129Xe for human lung imaging studies. Acad Radiol 2008, 15:683-692.
52. Driehuys B., Pollaro J., Cofer G.P. In vivo MRI using real-time production of hyperpolarized 129Xe. Magn Reson Med 2008, 60:14-20.
53. Shukla Y., Wheatley A., Kirby M., et al. Hyperpolarized (129)xe magnetic resonance imaging: tolerability in healthy volunteers and subjects with pulmonary disease. Acad Radiol 2012, 19:941-951.
54. Altes TA, Meyer CH, Mata JH, Froh D, Paget-Brown A, Fain S, et al. Hyperpolarized helium-3 MR imaging of a non-sedated infant: a proof-of-concept study. Proceedings of the 20th Annual Meeting of ISMRM, Melbourne, Australia, 1355. 2012. Ref Type: Abstract.
55. Altes T.A., Mata J., de Lange E.E., Brookeman J.R., Mugler J.P. Assessment of lung development using hyperpolarized helium-3 diffusion MR imaging. J Magn Reson Imaging 2006, 24:1277-1283.
56. Altes TA, Johnson M, Mugler JP, Froh D, Flors L, Miller GW, et al. Hyperpolarized helium-3 MRI detects the effects of a CFTR protentiator (Ivacaftor) thereapy in subjects with cystic fibrosis and the G551D mutation. Proceedings of the 20th Annual Meeting of ISMRM, Melbourne, Australia, 1359. 2012. Ref Type: Abstract.
57. Koumellis P., van Beek E.J., Woodhouse N., et al. Quantitative analysis of regional airways obstruction using dynamic hyperpolarized 3He MRI-preliminary results in children with cystic fibrosis. J Magn Reson Imaging 2005, 22:420-426.
58. van Beek E.J., Hill C., Woodhouse N., et al. Assessment of lung disease in children with cystic fibrosis using hyperpolarized 3-Helium MRI: comparison with Shwachman score, Chrispin-Norman score and spirometry. Eur Radiol 2007, 17:1018-1024.
59. Woodhouse N., Wild J.M., van Beek E.J., Hoggard N., Barker N., Taylor C.J. Assessment of hyperpolarized 3He lung MRI for regional evaluation of interventional therapy: a pilot study in pediatric cystic fibrosis. J Magn Reson Imaging 2009, 30:981-988.
60. Bannier E., Cieslar K., Mosbah K., et al. Hyperpolarized 3He MR for sensitive imaging of ventilation function and treatment efficiency in young cystic fibrosis patients with normal lung function. Radiology 2010, 255:225-232.
61. Salerno M., de Lange E.E., Altes T.A., Truwit J.D., Brookeman J.R., Mugler J.P. Emphysema: hyperpolarized helium 3 diffusion MR imaging of the lungs compared with spirometric indexes--initial experience. Radiology 2002, 222:252-260.
62. Saam B.T., Yablonskiy D.A., Kodibagkar V.D., et al. MR imaging of diffusion of (3)He gas in healthy and diseased lungs. Magn Reson Med 2000, 44:174-179.
63. Salerno M., Altes T.A., Brookeman J.R., de Lange E.E., Mugler J.P. Rapid hyperpolarized 3He diffusion MRI of healthy and emphysematous human lungs using an optimized interleaved-spiral pulse sequence. J Magn Reson Imaging 2003, 17:581-588.
64. Woodhouse N., Wild J.M., Paley M.N., et al. Combined helium-3/proton magnetic resonance imaging measurement of ventilated lung volumes in smokers compared to never-smokers. J Magn Reson Imaging 2005, 21:365-369.
65. Mathew L., Kirby M., Etemad-Rezai R., Wheatley A., McCormack D.G., Parraga G. Hyperpolarized (3)He magnetic resonance imaging: preliminary evaluation of phenotyping potential in chronic obstructive pulmonary disease. Eur J Radiol 2011, 79:140-146.
66. Fain S.B., Altes T.A., Panth S.R., et al. Detection of age-dependent changes in healthy adult lungs with diffusion-weighted 3He MRI. Acad Radiol 2005, 12:1385-1393.
67. Diaz S., Casselbrant I., Piitulainen E., et al. Validity of apparent diffusion coefficient hyperpolarized 3He-MRI using MSCT and pulmonary function tests as references. Eur J Radiol 2009, 71:257-263.
68. Kirby M., Svenningsen S., Owrangi A., et al. Hyperpolarized 3He and 129Xe MR Imaging in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease. Radiology 2012.
69. Fain S.B., Gonzalez-Fernandez G., Peterson E.T., et al. Evaluation of structure-function relationships in asthma using multidetector CT and hyperpolarized He-3 MRI. Acad Radiol 2008, 15:753-762.
70. Fain S.B., Panth S.R., Evans M.D., et al. Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging. Radiology 2006, 239:875-883.
71. Parraga G., Ouriadov A., Evans A., et al. Hyperpolarized 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3.0 Tesla. Invest Radiol 2007, 42:384-391.
72. Mathew L., Evans A., Ouriadov A., et al. Hyperpolarized 3He magnetic resonance imaging of chronic obstructive pulmonary disease: reproducibility at 3.0 tesla. Acad Radiol 2008, 15:1298-1311.
73. Morbach A.E., Gast K.K., Schmiedeskamp J., et al. Diffusion-weighted MRI of the lung with hyperpolarized helium-3: a study of reproducibility. J Magn Reson Imaging 2005, 21:765-774.
74. Diaz S., Casselbrant I., Piitulainen E., et al. Hyperpolarized 3He apparent diffusion coefficient MRI of the lung: reproducibility and volume dependency in healthy volunteers and patients with emphysema. J Magn Reson Imaging 2008, 27:763-770.
75. Woods J.C., Choong C.K., Yablonskiy D.A., et al. Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema. Magn Reson Med 2006, 56:1293-1300.
76. Butler J.P., Loring S.H., Patz S., Tsuda A., Yablonskiy D.A., Mentzer S.J. Evidence for adult lung growth in humans. N Engl J Med 2012, 367:244-247.
77. de Lange E.E., Altes T.A., Patrie J.T., et al. The variability of regional airflow obstruction within the lungs of patients with asthma: assessment with hyperpolarized helium-3 magnetic resonance imaging. J Allergy Clin Immunol 2007, 119:1072-1078.
78. de Lange E.E., Altes T.A., Patrie J.T., et al. Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry. Chest 2006, 130:1055-1062.
79. Altes T.A., Powers P.L., Knight-Scott J., et al. Hyperpolarized 3He MR lung ventilation imaging in asthmatics: preliminary findings. J Magn Reson Imaging 2001, 13:378-384.
80. Kirby M., Mathew L., Wheatley A., Santyr G.E., McCormack D.G., Parraga G. Chronic obstructive pulmonary disease: longitudinal hyperpolarized (3)He MR imaging. Radiology 2010, 256:280-289.
81. Mathew L., Gaede S., Wheatley A., Etemad-Rezai R., Rodrigues G.B., Parraga G. Detection of longitudinal lung structural and functional changes after diagnosis of radiation-induced lung injury using hyperpolarized 3He magnetic resonance imaging. Med Phys 2010, 37:22-31.
82. Parraga G., Mathew L., Etemad-Rezai R., McCormack D.G., Santyr G.E. Hyperpolarized 3He magnetic resonance imaging of ventilation defects in healthy elderly volunteers: initial findings at 3.0 Tesla. Acad Radiol 2008, 15:776-785.
83. de Lange E.E., Altes T.A., Patrie J.T., et al. Changes in regional airflow obstruction over time in the lungs of patients with asthma: evaluation with 3He MR imaging. Radiology 2009, 250:567-575.
84. Mentore K., Froh D.K., de Lange E.E., Brookeman J.R., Paget-Brown A.O., Altes T.A. Hyperpolarized HHe 3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment. Acad Radiol 2005, 12:1423-1429.
85. Altes T.A., Rehm P.K., Harrell F., Salerno M., Daniel T.M., de Lange E.E. Ventilation imaging of the lung: comparison of hyperpolarized helium-3 MR imaging with Xe-133 scintigraphy. Acad Radiol 2004, 11:729-734.
86. Lee E.Y., Sun Y., Zurakowski D., Hatabu H., Khatwa U., Albert M.S. Hyperpolarized 3He MR imaging of the lung: normal range of ventilation defects and PFT correlation in young adults. J Thorac Imaging 2009, 24:110-114.
87. Kirby M., Heydarian M., Svenningsen S., et al. Hyperpolarized (3)he magnetic resonance functional imaging semiautomated segmentation. Acad Radiol 2012, 19:141-152.
88. Tustison N.J., Avants B.B., Flors L., et al. Ventilation-based segmentation of the lungs using hyperpolarized (3)He MRI. J Magn Reson Imaging 2011, 34:831-841.
89. Tustison N.J., Altes T.A., Song G., de Lange E.E., Mugler J.P., Gee J.C. Feature analysis of hyperpolarized helium-3 pulmonary MRI: a study of asthmatics versus nonasthmatics. Magn Reson Med 2010, 63:1448-1455.
90. Wine J.J. The genesis of cystic fibrosis lung disease. J Clin Invest 1999, 103:309-312.
91. Tiddens H.A., Brody A.S. Monitoring cystic fibrosis lung disease in clinical trials: is it time for a change?. Proc Am Thorac Soc 2007, 4:297-298.
92. Brody A.S., Tiddens H.A., Castile R.G., et al. Computed tomography in the evaluation of cystic fibrosis lung disease. Am J Respir Crit Care Med 2005, 172:1246-1252.
93. Brody A.S., Sucharew H., Campbell J.D., et al. Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med 2005, 172:1128-1132.
94. Donnelly L.F., MacFall J.R., McAdams H.P., et al. Cystic fibrosis: combined hyperpolarized 3He-enhanced and conventional proton MR imaging in the lung--preliminary observations. Radiology 1999, 212:885-889.
95. McMahon C.J., Dodd J.D., Hill C., et al. Hyperpolarized 3helium magnetic resonance ventilation imaging of the lung in cystic fibrosis: comparison with high resolution CT and spirometry. Eur Radiol 2006, 16:2483-2490.
96. Kirby M., Svenningsen S., Ahmed H., et al. Quantitative evaluation of hyperpolarized helium-3 magnetic resonance imaging of lung function variability in cystic fibrosis. Acad Radiol 2011, 18:1006-1013.
97. Altes TA, Johnson M, Mugler JP, Miller GW, Flors L, Mata J., et al. The effect of ivacaftor, an investigational CFTR potentiator, on hyperpolarized noble gas magnetic resonance imaging in subjcts with cystic fibrosis who have the G551D-CFTR mutation. Am.J. Respir Crit Care Med 185, A2814. 2012. Ref Type: Abstract.
98. Wood R.A. Pediatric asthma. JAMA 2002, 288:745-747.
99. Samee S., Altes T., Powers P., et al. Imaging the lungs in asthmatic patients by using hyperpolarized helium-3 magnetic resonance: assessment of response to methacholine and exercise challenge. J Allergy Clin Immunol 2003, 111:1205-1211.
100. Costella S., Kirby M., Maksym G.N., McCormack D.G., Paterson N.A., Parraga G. Regional Pulmonary Response to a Methacholine Challenge using Hyperpolarized (3) He Magnetic Resonance Imaging. Respirology 2012.
101. Wang C., Altes T.A., Mugler J.P., et al. Assessment of the lung microstructure in patients with asthma using hyperpolarized 3He diffusion MRI at two time scales: comparison with healthy subjects and patients with COPD. J Magn Reson Imaging 2008, 28:80-88.
102. Evans A., McCormack D., Ouriadov A., Etemad-Rezai R., Santyr G., Parraga G. Anatomical distribution of 3He apparent diffusion coefficients in severe chronic obstructive pulmonary disease. J Magn Reson Imaging 2007, 26:1537-1547.
103. Kirby M., Heydarian M., Wheatley A., McCormack D.G., Parraga G. Evaluating bronchodilator effects in chronic obstructive pulmonary disease using diffusion-weighted hyperpolarized helium-3 magnetic resonance imaging. J Appl Physiol 2012, 112:651-657.